Synbio International, Inc. SYIN
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 60.70K | 60.70K | |||
| Depreciation & Amortization | 7.00K | 7.00K | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 67.60K | 67.60K | |||
| Operating Income | -67.60K | -67.60K | |||
| Income Before Tax | -86.90K | -86.90K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -86.90K | -86.90K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -86.90K | -86.90K | |||
| EBIT | -67.60K | -67.60K | |||
| EBITDA | -60.70K | -60.70K | |||
| EPS Basic | 0.00 | 0.00 | |||
| Normalized Basic EPS | 0.00 | 0.00 | |||
| EPS Diluted | 0.00 | 0.00 | |||
| Normalized Diluted EPS | 0.00 | 0.00 | |||
| Average Basic Shares Outstanding | 351.32M | 351.32M | |||
| Average Diluted Shares Outstanding | 351.32M | 351.32M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||